1 everything you wanted to know about glps…. but were afraid to ask janet rose christensen,...

17
1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI BioPharma, Inc. Portland, OR [email protected]/503.227.00554

Upload: abraham-neal

Post on 17-Dec-2015

217 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

1

Everything You Wanted to Know About GLPs….

but were afraid to ask

Everything You Wanted to Know About GLPs….

but were afraid to ask

Janet Rose Christensen, M.S.P.H.Vice President, Regulatory Affairs and Quality

AVI BioPharma, Inc.

Portland, OR

[email protected]/503.227.00554

Janet Rose Christensen, M.S.P.H.Vice President, Regulatory Affairs and Quality

AVI BioPharma, Inc.

Portland, OR

[email protected]/503.227.00554

Page 2: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

2

OverviewOverview

Definitions Elements Concepts Application Challenges Pitfalls Summing it Up But first………

Definitions Elements Concepts Application Challenges Pitfalls Summing it Up But first………

Page 3: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

3

Who Am I?Who Am I?

25+ years in the industry Ethical drugs, biologics, devices Degrees from U of W Married with 2 dogs and 4 cats

25+ years in the industry Ethical drugs, biologics, devices Degrees from U of W Married with 2 dogs and 4 cats

Page 4: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

4

GLPs: DefinitionGLPs: Definition

Basis: 21 CFR Part 58: GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES

GLPs: Good Laboratory Practices Nonclinical laboratory study means in vivo or in vitro experiments in which

test articles are studied prospectively in test systems under laboratory conditions to determine their safety. The term does not include studies utilizing human subjects or clinical studies or field trials in animals. The term does not include basic exploratory studies carried out to determine whether a test article has any potential utility or to determine physical or chemical characteristics of a test article.

Basis: 21 CFR Part 58: GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES

GLPs: Good Laboratory Practices Nonclinical laboratory study means in vivo or in vitro experiments in which

test articles are studied prospectively in test systems under laboratory conditions to determine their safety. The term does not include studies utilizing human subjects or clinical studies or field trials in animals. The term does not include basic exploratory studies carried out to determine whether a test article has any potential utility or to determine physical or chemical characteristics of a test article.

Page 5: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

5

ExperimentExperiment

“An operation carried out under controlled conditions in order to discover an unknown effect or law, to test or establish a hypothesis, or to illustrate a known law.”

Merriam-Webster

“An operation carried out under controlled conditions in order to discover an unknown effect or law, to test or establish a hypothesis, or to illustrate a known law.”

Merriam-Webster

Page 6: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

6

“GLP” is Misused“GLP” is Misused

GLP does not mean: Requirements for recording QC data Requirements for any laboratory work (e.g., R&D or

QC) Definition of a material grade (“GLP-grade”)

GLP does not pertain to ANYTHING other than a nonclinical laboratory study.

GLP does not mean: Requirements for recording QC data Requirements for any laboratory work (e.g., R&D or

QC) Definition of a material grade (“GLP-grade”)

GLP does not pertain to ANYTHING other than a nonclinical laboratory study.

Page 7: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

7

ConceptsConcepts

GLPs have more specific requirements, compared with other regulations.

GLPs apply only to nonclinical safety studies. GLP studies can be in vitro or in vivo. Nonclinical studies are critical to any clinical

study leading through market application (drug, devices, biologics).

GLPs have more specific requirements, compared with other regulations.

GLPs apply only to nonclinical safety studies. GLP studies can be in vitro or in vivo. Nonclinical studies are critical to any clinical

study leading through market application (drug, devices, biologics).

Page 8: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

8

ApplicationApplication

IND Enabling Studies Toxicology Safety Pharmacology Genotoxicity

Marketing Application Studies Long-term toxicity Carcinogenicity Reproductive toxicity

IND Enabling Studies Toxicology Safety Pharmacology Genotoxicity

Marketing Application Studies Long-term toxicity Carcinogenicity Reproductive toxicity

Page 9: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

9

Applications - DetailsApplications - Details

Protocol format is defined Use it - the reviewers expect information provided in

a consistent manner for everyone. Think it through - deviations can be perceived

negatively. Prepare and approve protocol BEFORE starting

work (contractors expect this).

Protocol format is defined Use it - the reviewers expect information provided in

a consistent manner for everyone. Think it through - deviations can be perceived

negatively. Prepare and approve protocol BEFORE starting

work (contractors expect this).

Page 10: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

10

More DetailsMore Details

Quality Assurance Unit Responsibilities defined Study audits Master Schedule Report to management Final Report review/sign-off

Quality Assurance Unit Responsibilities defined Study audits Master Schedule Report to management Final Report review/sign-off

Page 11: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

11

More DetailsMore Details

Study Director The buck stops there Protocol Study execution Final Report

Study Director The buck stops there Protocol Study execution Final Report

Page 12: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

12

Other Details from GLPsOther Details from GLPs

Animal Care Standard operating Procedures Records Equipment Analytical methods (from a guidance document) Disqualification

Animal Care Standard operating Procedures Records Equipment Analytical methods (from a guidance document) Disqualification

Page 13: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

13

ChallengesChallenges

An IND/IDE/IAND-enabling study requires an articulation of the anticipated clinical plan. Route of administration Dose schedule Formulation Uses material representative of what will be use in

the clinic

An IND/IDE/IAND-enabling study requires an articulation of the anticipated clinical plan. Route of administration Dose schedule Formulation Uses material representative of what will be use in

the clinic

Page 14: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

14

Challenges (continued)Challenges (continued)

For a small company, there is a tendency to want the lowest cost - but you may pay for it later.

Apply the old adage: Fast Cheap PICK-TWO GLP-compliant

For a small company, there is a tendency to want the lowest cost - but you may pay for it later.

Apply the old adage: Fast Cheap PICK-TWO GLP-compliant

Page 15: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

15

PitfallsPitfalls

Not ensuring the test article is representative of the process, materials, etc., of the clinical product You may have to repeat the study Your clinical study could be delayed

Not using the data obtained from the study to establish monitoring in the human study.

Not reporting safety issues from a GLP study while the clinical study is occurring.

Not ensuring the test article is representative of the process, materials, etc., of the clinical product You may have to repeat the study Your clinical study could be delayed

Not using the data obtained from the study to establish monitoring in the human study.

Not reporting safety issues from a GLP study while the clinical study is occurring.

Page 16: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

16

More PitfallsMore Pitfalls

Assuming the contract lab knows what they’re doing (trust but verify)

Not seeking FDA concurrence of the study design before starting (risky)

Not carefully reviewing the draft report before sending it to FDA.

Not reporting ALL data obtained from a nonclinical study - you can discount it but you must report it.

Assuming the contract lab knows what they’re doing (trust but verify)

Not seeking FDA concurrence of the study design before starting (risky)

Not carefully reviewing the draft report before sending it to FDA.

Not reporting ALL data obtained from a nonclinical study - you can discount it but you must report it.

Page 17: 1 Everything You Wanted to Know About GLPs…. but were afraid to ask Janet Rose Christensen, M.S.P.H. Vice President, Regulatory Affairs and Quality AVI

17

Summing it Up…Summing it Up…

GLPs are specific in their requirements GLPs are critical to clinical trial subject safety GLP studies are critical elements for an IND,

leading to market approval.

GLPs are specific in their requirements GLPs are critical to clinical trial subject safety GLP studies are critical elements for an IND,

leading to market approval.